Mikaela Olsen
Oncology · Clarksville, MDNPI 1285233502
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (37.2%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. BD accounts for 75.6% of it on its own, with 32 other manufacturers making up the rest. 2025 is the largest year on record at $52,457, more than ten times the $323 reported in 2021.
Across 262 payments — averaging $497.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- BD$98K
- Biolife, L.L.C.$17K
- Bard Peripheral Vascular, Inc.$2K
- Koru Medical Systems, Inc.$2K
- AstraZeneca$1K
- Daiichi Sankyo Inc.$1K
- plus $8K from 27 others
What the payments were for
- Consulting fees$25,15719%
- Speaking & faculty fees$37,18929%
- Grants$3,5003%
- Travel & lodging$48,47437%
- Food & beverage$9,8158%
- Education$6,1205%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| BD | 71 | $98,494 |
| Biolife, L.L.C. | 10 | $17,315 |
| Bard Peripheral Vascular, Inc. | 5 | $2,361 |
| Koru Medical Systems, Inc. | 1 | $1,750 |
| AstraZeneca | 16 | $1,248 |
| Daiichi Sankyo Inc. | 13 | $1,120 |
| Johnson & Johnson | 23 | $922 |
| Genmab U.S., Inc. | 11 | $775 |
| Genentech USA, Inc. | 16 | $633 |
| E.r. Squibb & Sons, L.L.C. | 7 | $592 |
| Incyte Corporation | 6 | $515 |
| Taiho Oncology, Inc. | 7 | $489 |
| Amgen | 8 | $485 |
| Seagen Inc. | 5 | $440 |
| Stemline Therapeutics Inc. | 6 | $274 |
| Bristol Myers Squibb | 10 | $271 |
| BTG International Inc. | 2 | $268 |
| Ipsen Biopharmaceuticals, Inc | 4 | $232 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $221 |
| Bayer | 3 | $212 |
| Fennec Pharmaceuticals, Inc. | 2 | $212 |
| AbbVie | 3 | $210 |
| Sanofi | 2 | $207 |
| Regeneron Healthcare Solutions, Inc. | 3 | $199 |
| Lilly USA, LLC | 3 | $178 |
| Legend Biotech USA Inc. | 3 | $178 |
| Sanofi-aventis U.S. LLC | 1 | $125 |
| Novartis | 3 | $105 |
| Janssen Scientific Affairs, LLC | 3 | $66 |
| Gilead | 1 | $65 |
| Pfizer | 2 | $39 |
| Jazz Pharmaceuticals Inc. | 1 | $32 |
| Geron Corporation | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few oncology providers in Marylandto place this figure against a meaningful peer group, so we don't.
Other oncology in Clarksville
- Kathryn MooneyBaltimore$6K
- Laurie BryantBaltimore$1K
- Marie SwisherBaltimore$1K
- Leslie SmithBethesda$486
- Emily QuaglieriRockville$33
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.